Company intelligence / Profile preview

Nanjing Hicin Pharmaceutical Co., Ltd.

Nanjing, Jiangsu, Chinahicin.cn ↗
Ownership
Private
Employees
~553
Development stage
Commercial
01

Overview

Nanjing Hicin has a diversified portfolio of approved and pipeline drugs. Landiolol hydrochloride targeting β1 adrenergic receptor for cardiac arrhythmias has been approved. The company also inlicensed a global IDH inhibitor program from Nerviano Medical Sciences for AML. Its product range covers antivirals, antibiotics, endocrine drugs and more; several APIs are exported internationally. The company maintains modern GMP-compliant manufacturing facilities and an active R&D center.

Therapeutic areas
OncologyEndocrinologyImmunologyOtherGastroenterologyCardiovascularInfectious Diseases
Modalities
Small molecules
Industry
Biotech
02

Drug pipeline

4 assets

omeprazole sodium

Commercial
Indications
Gastrointestinal disorders

3 more assets in the full pipeline.

Request access →
03

Partnerships

Nerviano Medical Sciences Srl – global rights to IDH inhibitor I111b licensed in August 2019 for AML development/commercialization.

Beyond the preview

Go deeper on Nanjing Hicin Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanjing Hicin Pharmaceutical Co., Ltd..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call